- Home
- ROMA vs FBRX Comparison
ROMA vs FBRX Comparison
Compare ROMA & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROMA
- FBRX
- Stock Information
- Founded
- ROMA 2018
- FBRX N/A
- Country
- ROMA Hong Kong
- FBRX United States
- Employees
- ROMA N/A
- FBRX N/A
- Industry
- ROMA Savings Institutions
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ROMA Finance
- FBRX Health Care
- Exchange
- ROMA Nasdaq
- FBRX Nasdaq
- Market Cap
- ROMA 8.4M
- FBRX 8.3M
- IPO Year
- ROMA 2024
- FBRX N/A
- Fundamental
- Price
- ROMA $0.70
- FBRX $5.60
- Analyst Decision
- ROMA
- FBRX Strong Buy
- Analyst Count
- ROMA 0
- FBRX 3
- Target Price
- ROMA N/A
- FBRX $81.25
- AVG Volume (30 Days)
- ROMA 113.3K
- FBRX 12.9K
- Earning Date
- ROMA 11-26-2024
- FBRX 11-22-2024
- Dividend Yield
- ROMA N/A
- FBRX N/A
- EPS Growth
- ROMA N/A
- FBRX N/A
- EPS
- ROMA N/A
- FBRX N/A
- Revenue
- ROMA $1,265,509.00
- FBRX N/A
- Revenue This Year
- ROMA N/A
- FBRX N/A
- Revenue Next Year
- ROMA N/A
- FBRX N/A
- P/E Ratio
- ROMA N/A
- FBRX N/A
- Revenue Growth
- ROMA N/A
- FBRX N/A
- 52 Week Low
- ROMA $0.40
- FBRX $4.11
- 52 Week High
- ROMA $11.80
- FBRX $21.25
- Technical
- Relative Strength Index (RSI)
- ROMA 31.51
- FBRX 59.65
- Support Level
- ROMA $0.76
- FBRX $4.44
- Resistance Level
- ROMA $1.03
- FBRX $5.90
- Average True Range (ATR)
- ROMA 0.07
- FBRX 0.37
- MACD
- ROMA -0.04
- FBRX 0.20
- Stochastic Oscillator
- ROMA 1.85
- FBRX 82.36
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).